Edesa Biotech, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
EDSA Nasdaq 2836 www.edesabiotech.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Edesa Biotech, Inc.

EDSA: Advancing EB06 for the Treatment of Vitiligo… - May 19th, 2025 7:54 am
Positive Signs As Multiple Insiders Buy Edesa Biotech Stock - May 18th, 2025 6:51 am
Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results - May 14th, 2025 2:15 pm
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference - Apr 28th, 2025 2:30 pm
Edesa Biotech Announces Chief Financial Officer Transition - Apr 4th, 2025 2:15 pm
EDSA: Raises $15 Million to Advance EB06… - Mar 3rd, 2025 6:20 am
US Penny Stocks To Watch In February 2025 - Feb 14th, 2025 10:10 am
Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - Feb 13th, 2025 5:00 am
EDSA: IND Expected in 2025 for EB06 for the Treatment of Vitiligo… - Jan 22nd, 2025 4:23 am
Edesa Biotech And 2 Other Promising US Penny Stocks For Your Radar - Dec 17th, 2024 10:08 am
Edesa Biotech Reports Fiscal Year 2024 Results - Dec 13th, 2024 2:30 pm
Edesa Biotech’s Founder Makes Strategic Investment in the Company - Oct 31st, 2024 6:15 am
Edesa Biotech Announces Upcoming Conference Schedule - Oct 21st, 2024 6:15 am
EDSA: EB05 Selected for BARDA-Funded Study in ARDS… - Aug 20th, 2024 6:25 am